Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

8.38
Delayed Data
As of Dec 15
 +0.22 / +2.70%
Today’s Change
4.31
Today|||52-Week Range
21.38
-53.50%
Year-to-Date

Today’s Trading

Previous close8.16
Today’s open8.15
Day’s range8.13 - 8.45
Volume2,466,956
Average volume (3 months)1,626,421
Market cap$528.0M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)-42.67%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book2.07

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.07-0.87%
GLYCGlycoMimetics Inc+0.50+3.12%
AVEOAveo Pharmaceuticals...+0.01+0.34%
ACIUAC Immune SA+0.33+2.68%
Data as of 4:15pm ET, 12/15/2017

Financials

Next reporting dateFebruary 20, 2018
EPS forecast (this quarter)$0.11
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts